Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
Intravenous to subcutaneous tocilizumab switch is an effective and safe option in rheumatoid arthritis management, especially in the case of a shared decision.
Authors
- Alessandra Bortoluzzi (ORCID: https://orcid.org/0000-0003-2416-8134)
- Andrea Lotesoriere
- Carlo Garaffoni
- Marcello Govoni (ORCID: https://orcid.org/0000-0003-0499-5773)
- Ettore Silvagni (ORCID: https://orcid.org/0000-0001-7654-8222)
- Giorgio Galoppini (ORCID: https://orcid.org/0000-0003-1638-7310)
- Federico Nogarin
Institutions
- University of Ferrara (IT)
Publication Details
- Journal
- Biologics
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/btt.s555169
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00